Evidence map›Paper›PMID 30790072›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2019

Three-dimensional pattern of extraretinal neovascular development in retinopathy of prematurity.

Shwetha Mangalesh, Isaac D Bleicher, Xi Chen, Christian Viehland, Francesco LaRocca, Joseph A Izatt, Sharon F Freedman, M Elizabeth Hartnett, Cynthia A Toth

3 registry-linked trialsAbstract read
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02887157 completednot on this map

Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care (BabySTEPS)

TypeobservationalSponsorDuke UniversityRan2016 to 2021Enrolled191ConditionsRetinopathy of Prematurity, Neurodevelopmental Disorders, Macular EdemaArmsSwept Source OCT, Magnetic Resonance Imaging, Scavenged blood collection
NCT04995341 narecruitingnot on this mapstarted 2021, after this paper: background citation

Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care 2 and School Age Follow on Study (BabySTEPS2)

TypeinterventionalSponsorDuke UniversityRan2021 to 2027Enrolled236ConditionsRetinopathy of PrematurityArmsInvestigational ultracompact OCT and OCTA system, retinal photographs
NCT06139523 recruitingnot on this mapstarted 2024, after this paper: background citation

Optimize Pediatric OCT (Optical Coherence Tomography) Imaging: a Pilot Study

TypeobservationalSponsorDuke UniversityRan2024 to 2027Enrolled30ConditionsRetinal Disease, Glaucoma, Optic Nerve DiseasesArmsInvestigational contact OCT system, Investigational noncontact OCT system:
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Utility of handheld optical coherence tomography imaging in the surgical management of preterm infants with advanced retinopathy of prematurity.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Insights into the developing fovea revealed by imaging.Progress in retinal and eye research · 2022
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shwetha MangaleshDepartment of Ophthalmology, Duke University School of Medicine, 2351 Erwin Road-Suite 1002 AERI, Durham, NC, 27710, USA.
Isaac D BleicherDepartment of Ophthalmology, Duke University School of Medicine, 2351 Erwin Road-Suite 1002 AERI, Durham, NC, 27710, USA.
Xi ChenDepartment of Ophthalmology, Duke University School of Medicine, 2351 Erwin Road-Suite 1002 AERI, Durham, NC, 27710, USA.
Christian ViehlandDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Francesco LaRoccaDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Joseph A IzattDepartment of Ophthalmology, Duke University School of Medicine, 2351 Erwin Road-Suite 1002 AERI, Durham, NC, 27710, USA.
Sharon F FreedmanDepartment of Ophthalmology, Duke University School of Medicine, 2351 Erwin Road-Suite 1002 AERI, Durham, NC, 27710, USA.
M Elizabeth HartnettDepartment of Ophthalmology, Moran Eye Center, University of Utah, Salt Lake City, UT, USA.
Cynthia A TothDepartment of Ophthalmology, Duke University School of Medicine, 2351 Erwin Road-Suite 1002 AERI, Durham, NC, 27710, USA. cynthia.toth@dm.duke.edu.ORCID http://orcid.org/0000-0002-2324-0854
Duke University · USUniversity of Utah · US

Funding

Scientific TransparencyP30EY001583 · NEI · UNIVERSITY OF PENNSYLVANIA · PI William A. Beltran · 1985 to 2026
$19.5M
Endothelial Transmigration in Neovascular Age-related Macular DegenerationR01EY017011 · NEI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HARTNETT, MARY ELIZABETH RUTH · 2007 to 2025
$7.7M
Mechanisms of Angiogenesis of Retinopathy of PrematurityR01EY015130 · NEI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Mary Elizabeth Ruth Hartnett · 2005 to 2026
$7.6M
Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve CareR01EY025009 · NEI · DUKE UNIVERSITY · PI Xi Chen, CYNTHIA ANN TOTH · 2016 to 2026
$6.6M
Retinal Neurovascular Patterning in Preterm InfantsK23EY028227 · NEI · DUKE UNIVERSITY · PI CHEN, XI · 2017 to 2021
$929k
Bayer Corporation Bayer Global Ophthalmology Awards ProgramHartwell Foundation Hartwell Foundation GrantNEI NIH HHS K23 EY028227NEI NIH HHS K23EY028227NEI NIH HHS P30 EY001583NEI NIH HHS R01 EY015130NEI NIH HHS R01 EY017011NEI NIH HHS R01 EY025009NEI NIH HHS RO1 EY025009Research to Prevent Blindness Career Development AwardResearch to Prevent Blindness Unrestricted GrantRockefeller Foundation Rockefeller Writing ResidencyThe Andrew Family Charitable Foundation Donation for research
6 · The paper itself

Abstract

backgroundThe application of three-dimensional (3D) visualization techniques to evaluate the earliest visible onset of abnormal retinal vascular development in preterm infants with retinopathy of prematurity (ROP), using bedside non-contact optical coherence tomography (OCT) imaging to characterize morphology and sequential structural changes of abnormal extraretinal neovascularization.

methodsThirty-one preterm infants undergoing routine ROP screening with written informed consent for research imaging were enrolled in this prospective observational study. We imaged the macula and temporal periphery of preterm infants using a handheld OCT system (Envisu 2300 or handheld swept-source research system). The scans obtained were segmented and, using enhanced ray casting, were converted to 3D volumes to which color filter was applied.

resultsUsing colorized 3D visualization, we defined extraretinal neovascular structures as buds, bridging networks, and placoid lesions. We could longitudinally follow progression and regression of extraretinal neovascularization in stage 3 ROP after treatment in one infant over 12 weeks and document the appearance of early buds, and formation of florid neovascularization. From stages 2 to 3 ROP, we observed progression from sessile buds to a complex plaque that corresponded to stage 3 ROP on clinical examination. We demonstrated regression of neovascular complexes to small pre-retinal tufts after treatment with anti-VEGF.

conclusionsThe extension of OCT processing to include surface flattening and colorization that further improved structural analysis rendered better understanding of extraretinal tissue. Our ability to image similar areas in the same infant over multiple visits enabled us to study the evolution of these structural components and follow pathological vascular events longitudinally in development and regression after treatment. These methods can be applied to further study which are likely contribute to our understanding of the pathophysiology of neovascularization in ROP.

Indexed as

Angiogenesis InhibitorsBevacizumabGestational AgeHumansImaging, Three-DimensionalInfantInfant, PrematureIntravitreal InjectionsProspective StudiesRetinal NeovascularizationRetinal VesselsRetinopathy of PrematurityTomography, Optical CoherenceVascular Endothelial Growth Factor AAngiogenesis InhibitorsBevacizumabVascular Endothelial Growth Factor AVEGFA protein, human3DOCTOptical coherence tomographyRetinopathy of prematurityROPVisualization

Identifiers

PMID30790072
PMCPMC6698900
OpenAlexW2915689521

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.